Sandoz’s Tyruko (natalizumab), the only FDA approved natalizumab biosimilar for adults with relapsing multiple sclerosis and Crohn’s disease, is now available by prescription in the United States ...

The companies’ drug Ziihera shows clinically meaningful benefits for patients with gastroesophageal adenocarcinoma.

Nearly three years after striking up a Zymeworks licensing pact with an eye on challenging the status quo in HER2-positive ...

The Danish drugmaker said it's cutting the price of Wegovy and Ozempic from $499 to $349 per month for some customers who buy ...

The road to wellness frequently depends on lifesaving pills, yet for millions, these same medications deliver a baffling ...

Many medications can cause memory loss, including benzodiazepines, opioids, certain antidepressants, and antihistamines.

UroGen is handing an anti-CTLA-4 antibody back to Agenus after concluding phase 1 data for the bladder cancer drug didn’t ...

President Trump wants pharmaceutical production to return to the United States. A shuttered factory in Louisiana shows how ...

McCartney will work with the brand on social content that spotlights Zyrtec’s products as essentials he will be taking throughout the “Weightless” tour.

US consumer health company Kimberly-Clark has agreed to acquire Johnson & Johnson (J&J) consumer health spinout Kenvue for ...

Irving-based Kimberly-Clark announced a blockbuster deal Monday morning to acquire consumer health care company Kenvue for ...

One of the biggest mergers of the year, worth $49 billion, comes just weeks after the Trump administration linked the common painkiller to autism, which the company is fighting.